• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠法尼醇 X 受体调节十二指肠表面积,但不控制小鼠的葡萄糖吸收。

Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice.

机构信息

Department of Pediatrics, University of Groningen, University Medical Center Groningen, 9700RB Groningen, The Netherlands.

Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, 9700RB Groningen, The Netherlands.

出版信息

Int J Mol Sci. 2023 Feb 18;24(4):4132. doi: 10.3390/ijms24044132.

DOI:10.3390/ijms24044132
PMID:36835544
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9961586/
Abstract

Bile acids facilitate the intestinal absorption of dietary lipids and act as signalling molecules in the maintenance of metabolic homeostasis. Farnesoid X receptor (FXR) is a bile acid-responsive nuclear receptor involved in bile acid metabolism, as well as lipid and glucose homeostasis. Several studies have suggested a role of FXR in the control of genes regulating intestinal glucose handling. We applied a novel dual-label glucose kinetic approach in intestine-specific FXR mice (iFXR-KO) to directly assess the role of intestinal FXR in glucose absorption. Although iFXR-KO mice showed decreased duodenal expression of hexokinase 1 () under obesogenic conditions, the assessment of glucose fluxes in these mice did not show a role for intestinal FXR in glucose absorption. FXR activation with the specific agonist GS3972 induced , yet the glucose absorption rate remained unaffected. FXR activation increased the duodenal villus length in mice treated with GS3972, while stem cell proliferation remained unaffected. Accordingly, iFXR-KO mice on either chow, short or long-term HFD feeding displayed a shorter villus length in the duodenum compared to wild-type mice. These findings indicate that delayed glucose absorption reported in whole-body FXR mice is not due to the absence of intestinal FXR. Yet, intestinal FXR does have a role in the small intestinal surface area.

摘要

胆汁酸促进膳食脂质的肠道吸收,并作为代谢稳态维持的信号分子发挥作用。法尼醇 X 受体 (FXR) 是一种胆汁酸反应性核受体,参与胆汁酸代谢以及脂质和葡萄糖稳态的调节。多项研究表明,FXR 在调节肠道葡萄糖处理的基因控制中发挥作用。我们在肠道特异性 FXR 敲除小鼠 (iFXR-KO) 中应用了一种新型的双标记葡萄糖动力学方法,直接评估肠道 FXR 在葡萄糖吸收中的作用。尽管 iFXR-KO 小鼠在肥胖条件下十二指肠中己糖激酶 1 () 的表达减少,但对这些小鼠葡萄糖通量的评估并未显示肠道 FXR 在葡萄糖吸收中的作用。用特异性激动剂 GS3972 激活 FXR 诱导了 ,但葡萄糖吸收率保持不变。FXR 激活增加了用 GS3972 治疗的小鼠十二指肠的绒毛长度,而干细胞增殖不受影响。因此,与野生型小鼠相比,无论是在标准饮食、短期还是长期高脂肪饮食喂养的 iFXR-KO 小鼠,其十二指肠中的绒毛长度更短。这些发现表明,全身性 FXR 敲除小鼠中报道的葡萄糖吸收延迟不是由于肠道 FXR 的缺失。然而,肠道 FXR 确实在小肠表面积中起作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/7859b432d186/ijms-24-04132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/11aa564f5bd0/ijms-24-04132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/27dbffd2e42d/ijms-24-04132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/90793de8a52a/ijms-24-04132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/7f34a4ee12d3/ijms-24-04132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/7859b432d186/ijms-24-04132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/11aa564f5bd0/ijms-24-04132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/27dbffd2e42d/ijms-24-04132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/90793de8a52a/ijms-24-04132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/7f34a4ee12d3/ijms-24-04132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/334a/9961586/7859b432d186/ijms-24-04132-g005.jpg

相似文献

1
Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice.肠法尼醇 X 受体调节十二指肠表面积,但不控制小鼠的葡萄糖吸收。
Int J Mol Sci. 2023 Feb 18;24(4):4132. doi: 10.3390/ijms24044132.
2
Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.肠道 FXR 介导体产生 FGF15 有助于小鼠肝脏胆汁酸合成的昼夜节律控制。
Lab Invest. 2010 Oct;90(10):1457-67. doi: 10.1038/labinvest.2010.107. Epub 2010 Jun 7.
3
A novel role for farnesoid X receptor in the bile acid-mediated intestinal glucose homeostasis.法尼醇 X 受体在胆汁酸介导的肠道葡萄糖稳态中的新作用。
J Cell Mol Med. 2020 Nov;24(21):12848-12861. doi: 10.1111/jcmm.15881. Epub 2020 Oct 8.
4
Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.法尼酯X受体(FXR)对肝脏脂质蓄积的保护作用由肝脏FXR介导,且独立于肠道FGF15信号。
Liver Int. 2015 Apr;35(4):1133-1144. doi: 10.1111/liv.12456. Epub 2014 Feb 7.
5
Bile acid treatment and FXR agonism lower postprandial lipemia in mice.胆汁酸治疗和法尼醇 X 受体激动剂可降低小鼠餐后血脂。
Am J Physiol Gastrointest Liver Physiol. 2020 Apr 1;318(4):G682-G693. doi: 10.1152/ajpgi.00386.2018. Epub 2020 Jan 31.
6
Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.肠法尼醇 X 受体控制小鼠肠内胆固醇排泄。
Gastroenterology. 2017 Apr;152(5):1126-1138.e6. doi: 10.1053/j.gastro.2016.12.037. Epub 2017 Jan 5.
7
Enterohepatic circulation of bile salts in farnesoid X receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein.法尼酯X受体缺陷小鼠中胆盐的肠肝循环:在缺乏回肠胆汁酸结合蛋白的情况下肠道对胆盐的有效吸收
J Biol Chem. 2003 Oct 24;278(43):41930-7. doi: 10.1074/jbc.M306309200. Epub 2003 Aug 12.
8
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.口服黄连素通过改变微生物胆汁酸代谢和肠道法尼醇X受体信号通路来调节肝脏脂质代谢。
Mol Pharmacol. 2017 Feb;91(2):110-122. doi: 10.1124/mol.116.106617. Epub 2016 Dec 8.
9
Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease.肠道选择性法尼醇X受体调节在代谢性疾病治疗中的潜力
Handb Exp Pharmacol. 2019;256:207-234. doi: 10.1007/164_2019_233.
10
Glucose sensing O-GlcNAcylation pathway regulates the nuclear bile acid receptor farnesoid X receptor (FXR).葡萄糖感应 O-GlcNAc 修饰途径调节核胆汁酸受体法尼醇 X 受体(FXR)。
Hepatology. 2014 May;59(5):2022-33. doi: 10.1002/hep.26710. Epub 2014 Mar 24.

引用本文的文献

1
Activation of farnesoid X receptor upregulates binding immunoglobulin protein expression and alleviates diabetic nephropathy.法尼醇X受体的激活上调结合免疫球蛋白蛋白表达并减轻糖尿病肾病。
World J Diabetes. 2025 Aug 15;16(8):105228. doi: 10.4239/wjd.v16.i8.105228.
2
Research progress on the relationship between bile acid metabolism and type 2 diabetes mellitus.胆汁酸代谢与2型糖尿病关系的研究进展
Diabetol Metab Syndr. 2023 Nov 17;15(1):235. doi: 10.1186/s13098-023-01207-6.
3
Nuclear Receptors in Health and Diseases.核受体在健康与疾病中的作用

本文引用的文献

1
Ablation of liver results in an increased colonic mucus barrier in mice.肝脏切除导致小鼠结肠黏液屏障增加。
JHEP Rep. 2021 Aug 4;3(5):100344. doi: 10.1016/j.jhepr.2021.100344. eCollection 2021 Oct.
2
Intestine-specific FXR agonists as potential therapeutic agents for colorectal cancer.肠特异性 FXR 激动剂作为结直肠癌的潜在治疗药物。
Biochem Pharmacol. 2021 Apr;186:114430. doi: 10.1016/j.bcp.2021.114430. Epub 2021 Feb 6.
3
Vertical sleeve gastrectomy confers metabolic improvements by reducing intestinal bile acids and lipid absorption in mice.
Int J Mol Sci. 2023 May 23;24(11):9153. doi: 10.3390/ijms24119153.
胃袖状切除术通过减少肠道胆汁酸和脂质吸收改善小鼠代谢。
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6). doi: 10.1073/pnas.2019388118.
4
Prophylactic Treatment with Vitamins C and B2 for Methotrexate-Induced Gastrointestinal Mucositis.维生素 C 和 B2 预防甲氨蝶呤致胃肠道黏膜炎
Biomolecules. 2020 Dec 29;11(1):34. doi: 10.3390/biom11010034.
5
High Fat Rodent Models of Type 2 Diabetes: From Rodent to Human.高脂啮齿动物 2 型糖尿病模型:从啮齿动物到人类。
Nutrients. 2020 Nov 27;12(12):3650. doi: 10.3390/nu12123650.
6
A novel role for farnesoid X receptor in the bile acid-mediated intestinal glucose homeostasis.法尼醇 X 受体在胆汁酸介导的肠道葡萄糖稳态中的新作用。
J Cell Mol Med. 2020 Nov;24(21):12848-12861. doi: 10.1111/jcmm.15881. Epub 2020 Oct 8.
7
Transcriptional programmes underlying cellular identity and microbial responsiveness in the intestinal epithelium.肠道上皮细胞的细胞身份和微生物反应性的转录程序。
Nat Rev Gastroenterol Hepatol. 2021 Jan;18(1):7-23. doi: 10.1038/s41575-020-00357-6. Epub 2020 Oct 6.
8
Open-label phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor agonist PX-104 in non-alcoholic fatty liver disease.一项开放性II期研究,评估非甾体类法尼醇X受体激动剂PX-104在非酒精性脂肪性肝病中的安全性和疗效。
Wien Klin Wochenschr. 2021 May;133(9-10):441-451. doi: 10.1007/s00508-020-01735-5. Epub 2020 Sep 15.
9
Enhanced alcoholic liver disease in mice with intestine-specific farnesoid X receptor deficiency.肠道特异性法尼醇 X 受体缺陷小鼠增强的酒精性肝病。
Lab Invest. 2020 Sep;100(9):1158-1168. doi: 10.1038/s41374-020-0439-y. Epub 2020 May 13.
10
Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria.甘氨熊脱氧胆酸(HDCA)通过 FXR-PI3K/AKT 通路抑制肠道上皮细胞增殖,同时伴有肠道细菌引起的胆汁酸代谢谱的改变。
FASEB J. 2020 May;34(5):7103-7117. doi: 10.1096/fj.201903244R. Epub 2020 Apr 4.